Sunday, June 14, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 975 of 1,261

  1. US 7872129

    Compositions useful as inhibitors of GSK-3

    Vertex Pharmaceuticals Incorporated · Granted Jan 18, 2011 · Expires Jan 13, 2031

    granted

  2. US 7871981

    Inhibition of cell motility, angiogenesis, and metastasis

    The United States of America, as represented by the Department of Health and Human Services · Granted Jan 18, 2011 · Expires Jan 13, 2031

    granted

  3. US 7871993

    Tigecycline crystalline forms and processes for preparation thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jan 18, 2011 · Expires Jan 13, 2031

    granted

  4. US 7871986

    Methods of stimulating an immune response against prostate specific antigen

    The United States of America, as represented by the Department of Health and Human Services · Granted Jan 18, 2011 · Expires Jan 13, 2031

    granted

  5. US 7871997

    Cephalosporin compounds

    Theravance, Inc. · Granted Jan 18, 2011 · Expires Jan 13, 2031

    granted

  6. US 7871985

    Compositions and methods for inhibiting expression of factor VII gene

    Alnylam Pharmaceuticals, Inc. · Granted Jan 18, 2011 · Expires Jan 13, 2031

    granted

  7. US 7871778

    Methods of diagnosing endometriosis

    The Regents of the University of California · Granted Jan 18, 2011 · Expires Jan 13, 2031

    granted

  8. US 7871607

    Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases

    HALOZYME, INC. · Granted Jan 18, 2011 · Expires Jan 13, 2031

    granted

  9. US 7872124

    Dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Jan 18, 2011 · Expires Jan 13, 2031

    granted

  10. US 7871814

    Recombinant bicistronic flaviviruses and methods of use thereof

    The Regents of the University of California · Granted Jan 18, 2011 · Expires Jan 13, 2031

    granted

  11. US 7871620

    Immunoliposomes that optimize internationalization into target cells

    The Regents of the University of California · Granted Jan 18, 2011 · Expires Jan 13, 2031

    granted

  12. US 7872082

    Method for preparing polymer maleimides

    Nektar Therapeutics · Granted Jan 18, 2011 · Expires Jan 13, 2031

    granted

  13. US 7872072

    Branched polymers and their conjugates

    Nektar Therapeutics · Granted Jan 18, 2011 · Expires Jan 13, 2031

    granted

  14. US 7871775

    Compositions and methods for the identification, assessment, prevention and therapy of human cancers

    The Board of Regents of the University of Texas System · Granted Jan 18, 2011 · Expires Jan 13, 2031

    granted

  15. US 7872000

    Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Jan 18, 2011 · Expires Jan 13, 2031

    granted

  16. US 7872096

    Methods for cyclizing synthetic polymers

    Rigel Pharmaceuticals, Inc. · Granted Jan 18, 2011 · Expires Jan 13, 2031

    granted

  17. US 7872031

    c-MET protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jan 18, 2011 · Expires Jan 13, 2031

    granted

  18. US 7872110

    Deimmunized monoclonal antibodies for protection against HIV exposure and treatment of HIV infection

    United Biomedical, Inc. · Granted Jan 18, 2011 · Expires Jan 13, 2031

    granted

  19. US 7867515

    Orally disintegrating solid dosage forms comprising progestin and methods of making and use thereof

    Teva Womans's Health, Inc. · Granted Jan 11, 2011 · Expires Jan 6, 2031

    granted

  20. US 7868160

    Compositions and methods for inhibiting expression of anti-apoptotic genes

    Alnylam Pharmaceuticals, Inc. · Granted Jan 11, 2011 · Expires Jan 6, 2031

    granted

  21. US 7868162

    Antimicrobial and antiviral compounds and methods for their use

    Lakewood Amedex, Inc. · Granted Jan 11, 2011 · Expires Jan 6, 2031

    granted

  22. US 7867974

    Induction of tolerance by oral administration of factor VIII and treatment of hemophilia

    The United States of America, as represented by the Department of Health and Human Services · Granted Jan 11, 2011 · Expires Jan 6, 2031

    granted

  23. US 7867171

    Management of gastro-intestinal disorders

    EXALENZ BIOSCIENCE LTD. · Granted Jan 11, 2011 · Expires Jan 6, 2031

    granted

  24. US 7867500

    Cofactor that modulates steroid receptor activities

    The United States of America, as represented by the Department of Health and Human Services · Granted Jan 11, 2011 · Expires Jan 6, 2031

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.